ArticleInfection and drug resistance2024
Tuberculosis Caused by Isoniazid-Resistant Strain Was Transmitted from a Woman Undergoing IVFET to Her Fetus by Intrauterine: A Case Report.
Article in Infection and drug resistance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tuberculosis (TB) among women and infants during the perinatal period is not rare, particularly in countries with a high TB burden. And the risk would increase significantly following in vitro fertilization-embryo transfer (IVFET). Worse still, TB in this stage is apt to develop into severe forms in women and neonates, such as disseminated TB or tuberculous meningitis (TBM). On the other hand, severe adverse effects (SAEs) of anti-tuberculosis (ATB) agents in neonates were common but difficult to diagnose early and manage well. Case Presentation: A 29-year-old mother receiving IVFET and her 3-month-old infant were diagnosed with disseminated tuberculosis and cranial tuberculoma on Dec 29, 2024, based on typical imaging features and bacteriological evidence. Intrauterine transmission of an isoniazid-resistant strain was confirmed through whole-genome sequencing (WGS) analysis and epidemiological investigation. ATB therapy and adjuvant treatment were initiated as soon as the confirmation of TB. Favorable therapeutic effects were achieved for them, and their condition stayed well until the last visit on Nov 19, 2024. However, the infant's ATB therapy had to be adjusted several times because of severe drug-induced liver injury (DILI) and lactic acidosis caused by ATB drugs during the treatment. In the end, he also obtained satisfactory outcomes. Conclusion: Clinicians should stay alert for TB in pregnant women who underwent IVFET as well as their neonates. Our case report may improve clinicians' awareness and ability to manage severe TB during the perinatal period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.